Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-11
1988-08-30
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540575, 544 60, 544 61, 544 62, 544126, 544361, 546 83, 514218, 514293, C07D40114, C07D47112
Patent
active
047677627
ABSTRACT:
This invention relates to novel isoxazolo-naphthyridine, isoxazolo-quinoline, isothiazolo-naphthyridine, and isothiazolo-quinoline, derivatives having antibacterial properties.
REFERENCES:
patent: 3541101 (1970-11-01), Markillie
patent: 4478834 (1984-10-01), Shroff et al.
patent: 4496566 (1985-01-01), Matsumoto et al.
patent: 4547503 (1985-10-01), Petersen et al.
patent: 4602014 (1986-07-01), Yokoyama
Tanasescu et al, Chem. Ber. vol. 92 (1959) pp. 2779-2783.
Abbott Laboratories
Katz Martin L.
Rizzo Nicholas S.
Shen Cecilia
Weinstock Steven F.
LandOfFree
Tricyclic quinoline and naphthyride antibacterials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic quinoline and naphthyride antibacterials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic quinoline and naphthyride antibacterials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2088422